These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7213116)

  • 41. [Myocardial protection utilizing hypothermia and cardioplegin during surgical correction of congenital heart disease (author's transl)].
    Hoffmeister HE; Seboldt H; Seybold-Epting W; Stunkat R
    Thoraxchir Vask Chir; 1978 Apr; 26(2):98-103. PubMed ID: 653708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of temperature of cardioplegic solution.
    Behrendt DM; Jochim KE
    J Thorac Cardiovasc Surg; 1978 Sep; 76(3):353-7. PubMed ID: 682667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraoperative myocardial protection by potassium arrest and local cardiac hypothermia.
    Bhayana JN; Gage AA
    Cryobiology; 1979 Dec; 16(6):526-33. PubMed ID: 544177
    [No Abstract]   [Full Text] [Related]  

  • 44. Warm cardiac surgery with continuous blood cardioplegia using a potassium infusion pump.
    Fried DW; Leo JJ; Mattioni GJ; Mohamed H; Zombolas TL; Weiss SJ
    Perfusion; 1997 Mar; 12(1):21-6. PubMed ID: 9131717
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical and experimental evaluation of myocardial protection by magenesium-procaine solution (Kirsh solution) and cold HES perfusion].
    Kato I; Kaihotsu N; Okada K; Fukuda T; Sugimoto T
    Nihon Kyobu Geka Gakkai Zasshi; 1978 Mar; 26(3):369-71. PubMed ID: 81251
    [No Abstract]   [Full Text] [Related]  

  • 46. [Myocardial protection during left-ventricular reconstruction in patients with an ejection fraction below 30].
    Bazylev VV; Rosseĭkin EV; Kobzev EE; Evdokimov ME
    Angiol Sosud Khir; 2017; 23(4):135-139. PubMed ID: 29240067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A comparative assessment of the myocardium protection by methods of blood and crystalloid cardioplegia in patients with high risk of coronary bypass grafting operation].
    Khudonogova SV; Kurapeev IS; Naĭmushin AV; Gordeev ML
    Vestn Khir Im I I Grek; 2002; 161(5):19-22. PubMed ID: 12661241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induced ischemic cardiac arrest. Clinical and experimental results with magnesium-aspartate-procaine solution (Cardioplegin).
    Kalmár P; Bleese N; Döring V; Gercken G; Kirsch U; Lierse W; Pokar H; Polonius MJ; Rodewald G
    J Cardiovasc Surg (Torino); 1975; 16(5):470-5. PubMed ID: 1194331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the dog.
    Rosenfeldt FL; Hearse DJ; Canković-Darracott S; Braimbridge MV
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):29-38. PubMed ID: 7350386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative myocardial protection with calcium-free versus calcium-containing potassium cardioplegic solutions.
    Magee PG; Gardner TJ; Flaherty JT; Bulkley BH; Goldman RA; Gott VL
    J Surg Res; 1980 Aug; 29(2):161-71. PubMed ID: 7412259
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of crystalloid and blood cardioplegic solutions on myocardial cooling during myocardial revascularization.
    Landymore RW; Kinley CE
    Can J Surg; 1984 May; 27(3):257-9. PubMed ID: 6609757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Myocardial protection: which method of cardioplegia is better?].
    Nasvytis L; Sirvinskas E
    Medicina (Kaunas); 2002; 38(8):797-800. PubMed ID: 12474750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of combined antegrade-retrograde infusion of blood cardioplegic solution in pediatric patients undergoing heart operations.
    Drinkwater DC; Cushen CK; Laks H; Buckberg GD
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1349-55. PubMed ID: 1434716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection of the myocardium during surgery.
    Bentall H
    J Cardiovasc Surg (Torino); 1975; 16(3):228-31. PubMed ID: 1150729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the rat.
    Hearse DJ; Stewart DA; Braimbridge MV
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):39-43. PubMed ID: 7350387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effectiveness of topical cardiac hypothermia.
    Stiles QR; Hughes RK; Lindesmith GG
    J Thorac Cardiovasc Surg; 1977 Feb; 73(2):176-80. PubMed ID: 299902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Some doubts about potassium cardioplegia.
    Lolley DM; Ray JF; Myers WO; Sautter RD
    Surgery; 1979 Mar; 85(3):360-2. PubMed ID: 425012
    [No Abstract]   [Full Text] [Related]  

  • 58. Conduction block after cardioplegic arrest: prevention by augmented atrial hypothermia.
    Smith PK; Buhrman WC; Ferguson TB; Levett JM; Cox JL
    Circulation; 1983 Sep; 68(3 Pt 2):II41-8. PubMed ID: 6872194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potassium ion as a cardioplegic agent in total cardiac bypass and during hypothermia with coronary perfusion: an experimental study.
    KAPLAN A; FISHER B
    J Thorac Cardiovasc Surg; 1960 Apr; 39():468-77. PubMed ID: 14404368
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of hypothermic hyperkalemic cardioplegic arrest on ventricular performance during cardiac surgery.
    Strom J; Becker RM; Frishman W; Elkayam U; Sonnenblick E; Oka Y; Tse Lin Y; Patel J; Frater RW
    N Y State J Med; 1978 Dec; 78(14):2210-3. PubMed ID: 310089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.